NICOLE STIPO: Open Payments
NPI 1942411582 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $587
Food & beverage: $507Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $135 |
| SANOFI US SERVICES INC. | 1 | $104 |
| Incyte Corporation | 2 | $98 |
| SpringWorks Therapeutics, Inc. | 1 | $61 |
| GENZYME CORPORATION | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
| Eisai Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| BeOne Medicines USA, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: RYBREVANT, OPDIVO, Lenvima, KEYTRUDA, BRUKINSA, IMFINZI, POTELIGEO, SARCLISA.
Industry payments across DE — which companies pay providers there.
